Jack Nathan Medical Corp.
JNHMF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | -0.00 | 0.02 |
| FCF Yield | -54.49% | -234.68% | -15.10% | -24.31% |
| EV / EBITDA | 1.12 | 0.25 | 14.84 | -17.15 |
| Quality | ||||
| ROIC | -67.23% | -119.95% | 61.35% | -50.19% |
| Gross Margin | -3.77% | 82.88% | 72.50% | 81.66% |
| Cash Conversion Ratio | 1.05 | 1.15 | -0.21 | 0.52 |
| Growth | ||||
| Revenue 3-Year CAGR | -40.94% | -18.34% | -8.39% | 10.47% |
| Free Cash Flow Growth | 96.06% | 64.65% | -225.82% | -9.69% |
| Safety | ||||
| Net Debt / EBITDA | 1.30 | 0.86 | -1.51 | -13.21 |
| Interest Coverage | -46.16 | -73.96 | 0.00 | -2.30 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 46.89 |
| Cash Conversion Cycle | -167.15 | -424.68 | -148.38 | -332.42 |